The Mycotoxin Testing Market was valued at USD 826.8 Million in 2019 and it is projected to reach USD 1,551.0 Million by 2028 with a CAGR of 7.2% during the forecast period, 2017-2028. According to the Food and Agriculture Organization (Italy), approximately 25% of the food produced globally contains harmful chemicals that are toxic in nature and are called mycotoxins.
Get free sample copy of this report @ https://bit.ly/3AvcMws
Key developments:
- January 2019, Bureau Veritas and AsureQuality announced that they had collaborated to form a new food testing company that is based out of Singapore and that will provide the finest food and water testing capabilities and equipment services to the Asia region.
- November 2017, Eurofins Scientific announced that they had acquired Spectro Analytical Labs Ltd. By this acquisition, Eurofins will be able to provide their expertise in testing & analysis to India and the neighboring regions.
Competitive Landscape
Companies are continuously investing in R&D activities of mycotoxin testing technologies and equipment. Some other key players profiled in the report are SGS S.A, Bureau Veritas, Eurofins, Intertek, Mérieux NutriSciences, ALS Limited, Neogen, Romer Labs, Symbio Laboratories, OMIC USA, AsureQuality, Microbac, among others.
Get free PDF of this report @ https://bit.ly/2ZlI5fF
The Global Asthma and COPD Drugs Market is expected to reach USD 62.32 billion by 2028 from USD 43.19 billion in 2019, growing at a CAGR of 4.2% during the forecast period.
Increasing asthma and COPD incidence and prevalence, advances in technology, and the rising senescent population is expected to propel the asthma and COPD drugs market during the forecast period.Get free sample copy of this report @ https://bit.ly/3m3lbRH Key Developments in the Asthma and COPD Drugs Market:In 2016, GlaxoSmithKline bought global rights to an experimental drug from Johnson and Johnson, raising its bet on a new generation of biotech medicines for severe asthma.
The British drugmaker launched Nucala, its first injectable biological asthma drug, and is looking for additional treatments to help more patients who are still struggling with breathing problems.In 2018, AstraZeneca unloaded rights to Alvesco (ciclesonide) to treat persistent asthma, and Omnaris and Zetonna (ciclesonide) to treat nasal symptoms associated with rhinitis.
The company indicates that the rights cover markets outside the United States and the US royalties for the drugs.
Covis already commercializes the three drugs in the US, but upon closing, it will own them.In 2015, AstraZeneca announced that it has entered into a definitive agreement to acquire the core respiratory business of Takeda Pharmaceutical Company Limited (“Takeda”).
The deal will include the expansion of rights to roflumilast (marketed as Daliresp in the US and Texas in other countries), the only approved oral PDE4 inhibitor for the treatment of chronic obstructive pulmonary disease (COPD).
The report "Medical Connectors Market by Product (Flat Silicone, Hybrid, Embedded, Radio Frequency, Push-Pull), Application (Patient Monitoring, Electrosurgery, Endoscopy, Diagnostic Imaging, Respiratory, Dental Device) & by End User - Global Forecast to 2021", report provides a detailed overview of the major drivers, restraints, trends, opportunities, and strategies impacting the medical connectors market along with the estimates and forecasts of the revenue and market share analysis.Browse 65 market data tables and 42 figures spread through 132 pages and in-depth TOC on "Medical Connectors Market by Product (Flat Silicone, Hybrid, Embedded, Radio Frequency, Push-Pull), Application (Patient Monitoring, Electrosurgery, Endoscopy, Diagnostic Imaging, Respiratory, Dental Device) & by End User - Global Forecast to 2021"Get Free PDF - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81731061The medical connectors market is projected to reach USD 2.69 Billion by 2021 from USD 1.63 Billion in 2016, at a CAGR of 10.5%.
The major factors driving the growth of this market are increasing incidence and prevalence of chronic diseases, rapid growth in the medical devices market, and growth in the home healthcare market, which results in increased adoption of miniaturized connectors and growing healthcare expenditure across the globe.The medical connectors market is segmented based on products, application, end user, and region in this report.
On the basis of products, the market is segmented into flat surgical silicone cables, embedded electronics connectors, radio-frequency connectors, disposable plastic connectors, hybrid circular connectors & receptacle system, power cords with retention system, lighted hospital-grade cords, magnetic medical connectors, and push-pull connectors.
The flat surgical silicone cables segment is expected to grow at the highest CAGR during the forecast period.
Increasing awareness about the application of connectors and its technical features are the factors driving the growth of this segment.The market is classified into cardiology devices, diagnostic imaging devices, electrosurgical instruments, patient monitoring devices, endoscopy devices, respiratory devices, analyzers and processing instruments, dental instruments, neurology devices, enteral devices, and other applications.
The patient monitoring devices segment is expected to grow at the highest CAGR during the forecast period due to increasing incidence of chronic diseases and increasing adoption of patient monitoring devices.Know more about Medical Connectors Market - https://www.marketsandmarkets.com/PressReleases/medical-connector.asp
The global Capacitive Proximity Sensor Market was valued at USD 0.80 billion in 2017 and is expected to reach a value of USD 1.21 billion by end of 2023, registering a CAGR of 7.19% during the forecast period (2018 - 2023).
The scope of the report includes various segments by type cylindrical capacitive sensor, and rectangular capacitive sensor, and is limited to aerospace & defense, industrial, automotive and marine end-user industries.
While the region considered in the scope of the report include North America, Europe, Asia pacific, Middle East & Africa and Latin America.Ask for Sample PDF @ http://www.orbisresearch.com/contacts/request-sample/2131973 One of the Major Drivers for the Capacitive Proximity Sensor Market is the Growth in Industrial AutomationThe industrial automation segment has been emerging to be a relatively more attractive space for investment by organizations across the globe.
However, limitations in sensing capabilities and availability of other sensors at a lower cost might hinder the growth of the capacitive proximity sensor market.Automotive Industry Has the Highest Market Share during the Forecast PeriodDue to the increasing purchasing power of the millennial population, there is a continuous demand for passenger cars.
According to OICA, global passenger was estimated to be 72.10 million units in 2016 and the demand is expected to be continuing during the forecast period.For an average consumer, trucks are reliable options, as they have better fuel efficiency and safety features.
Premium vehicles and utilities continue to drive the sales of light vehicles, which cumulatively contribute to an increase in the demand for capacitive proximity sensors market during the forecast period.Application of Capacitive Proximity Sensor MarketCapacitive sensors can detect metal and non-metal objects rather nearly all other materials.
The research report on the Global Meat Testing Market prepared by Reports and Data provides a comprehensive evaluation of the recent market trends.
The report provides the market report abstract in detail, focusing on growth statistics, estimation of revenue shares and growth, market valuation, and also emphasizes the competitive landscape, business opportunities, and strategic alliances and approaches undertaken by the dominant industry players.
The research study on the global Meat Testing market provides a detail-oriented assessment of this market and provides an accurate evaluation of market tendencies such as revenue estimations and shares, current market value, future market valuation, and market size over the forecast years.The report is updated with the COVID-19 crisis and its subsequent impact on the economic scenario.
The report also provides a study about the COVID-19 impact on the market size and the aftereffects of the COVID-9 pandemic.Request a sample of Meat Testing market report @ https://www.reportsanddata.com/sample-enquiry-form/2046Market segmentation by Key Players: Eurofins Scientific, Intertek, Elisa Technologies, ALS Laboratories, Primier Analytical Services, Campden BRI, Romer Labs, Symbio Laboratories, Barrow Agee Laboratories, Super Meat, SGS SwitzerlandAn outline of the expected performance of the Meat Testing market is provided below.
The report also contains vital information relating to the major current and expected market trends and the estimated growth rate of the market.Significant components emphasized in the Global Meat Testing market report include:Growth rateCurrent Market TrendsIndustry drivers and RestraintsProduct/Service concentration ratioRegional segmentation of the marketOpportunities and risksCurrent and future challengesKey competitorsRevenue estimationConsumer growth rateThe report focuses on the evaluation of the Meat Testing market in major regions and the countries included in those regions.
The report provides details of the market considering the geographical landscape that includes North America, Latin America, Asia Pacific, Europe, and Middle East & Africa.
The Global Meat Testing Market report presents a comprehensive analysis of the Meat Testing market by offering valuable insights to assist the businesses and key players in formulating fruitful strategies during the forecast timeline of 2020-2026.
The report studies the historical data to provide an assessment of key segments and sub-segments, revenue, industrial chain analysis, and demand and supply data.
The report also sheds light on the technological breakthroughs and product advancements happening in the Meat Testing market.
According to the report, the Meat Testing industry is likely to witness significant growth over the projected timeline.The report also covers the impact of the COVID-19 pandemic on the Meat Testing market and major segments.
The pandemic has affected every industry vertical either positively or negatively.
The report also offers a thorough current and future analysis of the impact of the COVID-19 pandemic on the overall growth of the market.To get a sample PDF copy of the report, visit @ https://www.reportsanddata.com/sample-enquiry-form/2046The report presents a panoramic view of the competitive landscape of the Meat Testing market, covering details about the key manufacturers and companies, price analysis, revenue estimation, gross profit margins, business expansion plans, and other vital details that offers the readers deep insights into each company operating in the industry.
The market growth is largely driven by factors such as growing to fund for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, the development of enhanced solutions and improved image analysis, and the growing use of high-throughput flow cytometry and automated hematology analyzers.
The medical application segment will grow at the highest CAGR in the cell counting market.
Increasing government initiatives in stem cell research and the wide usage of cell counting in research are the major factors driving the growth of the research applications segment during the forecast period.
The large growth of this segment can be attributed to factors such as the growing number of proteomics, genomics, and stem cell research activities; increasing research funding; increasing investments by pharmaceutical and biotechnology companies; and the growing trend of research infrastructure modernization.
For More information Download the PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728The hospitals and diagnostic laboratories will grow at the highest CAGR during the forecast period.
The high growth of this segment can primarily be attributed to the growing regulatory approvals for cell culture-based vaccines, increasing pharmaceutical R expenditure, and commercial expansion of various pharmaceutical companies.
